ARTICLE | Management Tracks
GSK vet McLoughlin joins HilleVax as COO
Plus: Acadia alum Stankovic passes away and updates for AZ, Immunitas, Iktos, Certis and PepGen
January 19, 2024 1:06 AM UTC
HilleVax Inc. (NASDAQ:HLVX) hired Sean McLoughlin to succeed co-founder and COO Aditya Kohli, who will become CBO. McLoughlin, a 25-year veteran of GSK plc (LSE:GSK; NYSE:GSK), was most recently VP, global commercial leader for Arexvy, GSK’s RSV vaccine. Kohli is a venture partner at Frazier Life Sciences, which launched the biotech with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK).
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) said former President Srdjan “Serge” Stankovic passed away on Dec. 29 after a prolonged illness. Stankovic led Acadia’s R&D organization from 2015 until he retired in 2022, playing a key role in the biotech becoming a commercial company. ...